EO 14398; consumables (multi-well plates) for use in multielectrode array (MEA) systems ("MEA plates")
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75F40126D00015
- Awardee
-
Axion Biosystems, Inc. UEI XCMKL76UJL15
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 1 $51,900 obligated
Award facts
- Opportunity
-
- IDIQ for the purchase of consumables (multi-well plates) for use in Axion Biosystems Multielectrode Array systems Pre-Solicitation · 75F40126Q133126 · Posted May 27, 2026
- Combined order value
- $51,900 Current and potential, with all options
- Last date to order 4% complete
- IDV ceiling 9% used
- $600,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Food and Drug Administration awarded a single-award indefinite-delivery contract to Axion Biosystems, Inc. on August 17, 2026, for consumables (multi-well plates) for use in multielectrode array (MEA) systems, with a contract ceiling of $600,000.00 and ultimate completion date of August 16, 2031.
The contract requires supply of 12-, 48-, and 96-well plate configurations compatible with Axion Biosystems MEA systems, including specific models M768-tMEA-96W, M768-tMEA-48W, and M768-tMEA-48OPT. Plates must feature a minimum of 700 electrodes per plate and support real-time well-by-well signal review, adjustable filters, temperature and electrical stimulation control, automatic cardiac and neural network identification, and measurement of field potential duration, beat period, conduction velocity, spike amplitude, viability, firing rate, and burst characteristics for microphysiological studies using human induced pluripotent stem cells.
The period of performance runs from July 31, 2026, through July 30, 2027 (base year) plus four option years, extending through August 16, 2031. Delivery occurs within 30 days of order placement to the FDA Center for Drug Evaluation and Research in Silver Spring, Maryland. The FDA's Office of Acquisition and Grant Services issued the originating pre-solicitation on May 27, 2026, with capability statements due June 3, 2026.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| EO 14398; axion multi-well plates for use in the multielectrode array (MEA) maestro system | Food and Drug Administration | $51,900 |
Quick answers
Who was awarded contract 75F40126D00015?
75F40126D00015 was awarded to Axion Biosystems, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 17, 2026.
How much is contract 75F40126D00015 worth?
Orders under 75F40126D00015 have obligated $51,900. 75F40126D00015's own ceiling is $600,000.
How many orders have been placed under contract 75F40126D00015?
1 order has been placed under 75F40126D00015, the latest on August 18, 2026.
Who can order from contract 75F40126D00015?
75F40126D00015 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75F40126D00015 competed?
The extent of competition for 75F40126D00015 was competed under sap. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV